Business Wire

ICON’s Leadership and Performance in Phase 1 Clinical Trials Recognised in Independent Industry Benchmarking Report

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been rated as one of the top-performing contract research ...
Healio

‘Time to rethink’ when patients with cancer enroll in early-phase trials, researchers argue

Please provide your email address to receive an email when new articles are posted on . Researchers contend that patients with incurable cancer should be enrolled in early phase trials at a time when ...
ascopubs.org

Beginning at the End? Rethinking the Timing of Enrollment Into Early Phase Clinical Trials

Engaging Patients, Oncologists, and Primary Care Clinicians in the Care of Cancer Survivors: A Coordinated Care Model With System-Level Technology to Move the Outcomes Needle If a pilot was attempting ...
Nasdaq

Celcuity Reports Clinical Data from Two Early Phase Studies of Gedatolisib

• In the Phase 1 portion of the CELC-G-201 clinical trial evaluating gedatolisib plusdarolutamide in men with metastatic castration resistant prostate cancer (“mCRPC”),the six-month radiographic ...
ascopubs.org

Impact of Food and Drug Administration Project Optimus Guidance on Design of Early-Phase Clinical Trials

Recent Trends and Patient Outcomes of Phase I Trials: A Single-Institution Experience in the Era of New Therapeutic Agents This study reviewed all industry-sponsored phase I clinical trial protocols ...